On Tuesday, Tripadvisor Inc (NASDAQ:TRIP)’s shares inclined 3.35% to $70.06.
TripAdvisor(R), the world’s largest travel site*, declared its Travelers’ Choice(TM) awards for museums around the globe, top tips from contributors for visiting museums, in addition to top-rated value hotel options for travelers near award-winning museums.
In total, 591 winners were identified, counting the top 25 in the world and dedicated lists for Asia, Canada, Europe, India, South America, South Pacific, the U.K. and the U.S. The awards are based on the millions of valuable reviews and opinions from TripAdvisor travelers worldwide. Award winners were determined using an algorithm that took into account the quantity and quality of reviews for museums around the world, gathered over a 12-month period.
TripAdvisor, Inc. operates as an online travel company. The company operates through two segments, Hotel and Other. Its travel research platform aggregates reviews and opinions about accommodations, destinations, activities and attractions, and restaurants that enable consumers to plan and book hotels, vacation rentals, flights, activities and attractions, and restaurants.
Starwood Property Trust, Inc. (NYSE:STWD)’s shares gained 0.05% to $21.37.
Starwood Property Trust, Inc. (STWD) declared operating results for the fiscal quarter ended June 30, 2015. The Company’s second quarter 2015 Core Earnings (a non-GAAP financial measure) were $125.9 million, or $0.53 per diluted share. Not Taking Into Account one-time acquisition and pursuit costs of $4.9 million, the Company’s second quarter 2015 Core Earnings were $130.8 million, or $0.55 per diluted share.
GAAP net income for the second quarter of 2015 was $117.1 million, or $0.49 per diluted. Not Taking Into Account one-time acquisition and pursuit costs of $4.9 million, the Company’s second quarter 2015 GAAP net income was $122.0 million, or $0.51 per diluted share.
Starwood Property Trust, Inc. originates, acquires, finances, and manages commercial mortgage loans, other commercial real estate debt investments, commercial mortgage-backed securities, and other commercial real estate-related debt investments in the United States and Europe. It operates in two segments, Real Estate Lending, and Real Estate Investing and Servicing.
At the end of Tuesday’s trade, ONEOK, Inc. (NYSE:OKE)‘s shares surged 1.01% to $34.85.
ONE Gas, Inc. (OGS) is a natural gas distribution company and the successor to the company founded in 1906 as Oklahoma Natural Gas Company, which became ONEOK, Inc. (OKE) in 1980. On January 31, 2014, ONE Gas, Inc. (OGS) will present at the Bank of America Merrill Lynch Power & Gas Leaders Conference on Thurs., Sept. 17, 2015, in Boston, Mass.
ONEOK, Inc., through its general partner interests in ONEOK Partners, L.P., engages in the gathering, processing, storage, and transportation of natural gas in the United States. The company gathers, treats, fractionates, stores, and transports natural gas liquids (NGL), in addition to owns natural gas liquids gathering and distribution pipelines, natural gas liquids distribution and refined petroleum products pipelines, and terminal and storage facilities; and owns and operates interstate and intrastate regulated natural gas transmission pipelines and natural gas storage facilities, in addition to stores and distributes NGL products to petrochemical manufacturers, heating fuel users, ethanol producers, refineries, and propane distributors.
OvaScience Inc (NASDAQ:OVAS), ended its Tuesday’s trading session with -2.47% loss, and closed at $17.36.
OvaScienceSM (OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, declared recently the first published analysis of real-world patient experience comparing the AUGMENTSM fertility treatment to standard in vitro fertilization (IVF). In the same woman within the same IVF cycle, AUGMENT-treated eggs had statistically noteworthy higher rates of embryo selection and transfer based on standard embryo quality measures, which resulted in statistically noteworthyhigher rates of pregnancy, contrast to standard IVF.
The report, published recently in the peer-reviewed, Journal of Fertilization: In Vitro– IVF-Worldwide Reproductive Medicine, Genetic & Stem Cell Biology, comprises a formerly described subset of 25 patients at Fakih IVF in the United Arab Emirates (UAE) whose eggs were prospectively allocated to two treatment groups – one that received the AUGMENT treatment and the other that received standard IVF only. The publication also comprises the combined experience of more than 90 patients from Fakih IVF and TCART Fertility Partners in Canada that showed substantial improvements in pregnancy rates with the AUGMENT treatment contrast to the patients’ preceding IVF histories. The publication is accessible at http://www.ovascience.com/technology/publications. A presentation describing the findings is accessible on the Investors page at www.ovascience.com. The AUGMENT treatment is designed to improve egg health and is not accessible in the United States.
OvaScience, Inc., a life science company, engages in the discovery, development, and commercialization of new treatments for infertility. The company’s patented technology is based on the discovery of egg precursor (EggPC) cells, which are immature egg cells found in the protective outer layer of a woman’s own ovaries.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
